Latest Commercial Contracts News

Amaero has completed commissioning its second advanced atomizer at its Tennessee facility, reinforcing its production capacity and reaffirming strong revenue visibility for FY2026. The company’s strategic investments position it as a key domestic supplier in the US advanced manufacturing sector.

Singular Health Group has inked a $1.3 million contract with Provider Network Solutions to deploy its 3DICOM imaging platform across key US states, backed by an $8 million capital raise to fuel national expansion.

Dubber Corporation has initiated court proceedings against its former auditors following a $26.6 million misappropriation uncovered in FY24, aiming to restore financial stability by year-end.

Element 25 has locked in a $50 million senior debt facility from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, underpinning supply for its US battery materials plant.

Linius Technologies secures $3.3 million through share placement and convertible notes, appointing former AFL CEO Andrew Demetriou to its board as it accelerates commercial momentum under new leadership.

Metal Powder Works has doubled its production capacity for advanced metal powders using its patented DirectPowder™ process, achieving this milestone without additional capital expenditure. The company also cut production cycle times by up to 40%, positioning itself as a key US supplier for defence applications.

Nanollose Limited has appointed Andrew Moullin as its new CEO and Managing Director, aiming to leverage his extensive commercial expertise to fast-track the company’s microbial cellulose technology towards market readiness.

Amaero Ltd updates its financial outlook, targeting positive EBITDA by FY2027 and reaffirming a A$72 million capital investment plan despite delays in US Department of Defense contracts.

NRW Holdings faces a significant threat to its $113.3 million secured debt after the South Australian Government proposed legislation that could invalidate key lease agreements underpinning its security interests in Whyalla Ports.

Proteomics International Laboratories has secured a key Chinese patent for its OxiDx oxidative stress test, broadening its intellectual property coverage across major global markets until 2039. This milestone reinforces the company’s position in precision diagnostics for sports and veterinary health.

Rhythm Biosciences’ subsidiary Genetype has landed a pivotal 12-month contract with the University of Melbourne to provide advanced breast cancer risk assessments, marking a significant step in personalised cancer screening.

Metal Powder Works has secured a strategic contract with Westinghouse Electric Company to supply metal powders for additive manufacturing in nuclear applications, marking a key step in its growth trajectory.